The "Today" host underwent gastric bypass surgery in 2002 to help him lose weight.

The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned ...

(NewMediaWire) - November 11, 2024 - DALLAS GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 inhibitor ...

U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...

As open enrollment kicks off, employees may find an unpleasant surprise in their 2025 health insurance premiums. Increased adoption of GLP-1 drugs, rising catastrophic claims and other cost pressures ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

If you looked solely at its stock price, you might get the idea that Eli Lilly (NYSE: LLY) is having a bit of an off quarter.

Scientists will explore if a chemical mostly found in red grapes – and products made from red grapes, such as wine and juice – can help prevent bowel cancer as part of a major new trial. At such a ...

The study will use a purified form of the natural compound, with the trial also testing if drugs like aspirin and metformin can prevent the disease.

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...